@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo;
a np:Nanopublication .
}
sub:assertion {
sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
sub:version prov:value "1"^^xsd:integer .
rdf:object ns1:C0013227 "drug";
ns1:C0597357 "receptors";
ns1:C1167395 "host";
ns1:C1254351 "drug";
ns1:C3245505 "potential";
ns1:C4527371 "candidate";
ns1:C5203670 "COVID-19" .
rdf:predicate ns3:TRIPLE_UID:ggiljvum-TRIPLE-ABSTRACT-16 "bind" .
rdf:subject ns1:C0011777 "dexamethasone";
ns1:C0011816 "Dex" .
rdfs:Triple-UID ns2:TRIPLE_UID:ggiljvum-TRIPLE-ABSTRACT-16 "ggiljvum-TRIPLE-ABSTRACT-16" .
rdfs:sentence rdfs:label "The study demonstrates that dexamethasone (Dex) could bind to both the viral and host receptors as a potential drug candidate for COVID-19." .
rdfs:triple rdfs:label "dexamethasone ( Dex ) bind to both the viral and host receptors as a potential drug candidate for COVID-19" .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-07-25T21:45:45.370025"^^xsd:dateTime .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "E/z65HluM5Whqq52fZE6t0XncvBa40HN+dwjPyKTNkAX9Q1XHhbruQXlY+Ek2v8wnZZ2qt0LO13vTkYcLUPX8+fYC2vxHESWMOudQfku9wjbiJ4gKvNuq0nIDbIMDVnq9GirbiA4OeNlo3cdfyAXjM99PN7UFEerNqNiCrkVW4I=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-07-25T21:45:45.370025"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}